AMS-410 ER12

N/A

Report date: 2025/01/26 17:12:50
NME

Base Information

Drug NameAMS-410 ER12
Drug Alias Nameketamine analog (Amorsa Therapeutics)KA-ER12 (Amorsa Therapeutics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsDepressionPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmorsa Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmorsa Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsDepression

Other Information

ATC CodeN/A
Related LinksN/A